Viewing Study NCT02866006


Ignite Creation Date: 2025-12-26 @ 1:16 PM
Ignite Modification Date: 2026-03-01 @ 2:26 AM
Study NCT ID: NCT02866006
Status: COMPLETED
Last Update Posted: 2022-10-12
First Post: 2016-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability Evaluation Study of BVAC-C in Patients With HPV Type 16 or 18 Positive Cervical Cancer
Sponsor: Cellid Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Uterine Cervical Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HPV View
None Type 16, 18 View
None E6E7 View
None Immune therapeutic vaccine View